Aureogen Biosciences

AureoGen Biosciences is a biotechnology company dedicated to developing innovative antibiotics derived from cyclic peptides, employing advanced genetic engineering, chemistry, and chemoenzymatic synthesis techniques. Their mission is to address the urgent challenge of antibiotic resistance by creating novel compounds with improved therapeutic properties.

The company's drug development pipeline focuses on antifungal and antibacterial programs, aiming to combat drug-resistant infections such as MRSA and Pseudomonas aeruginosa. With a commitment to providing new treatment options, AureoGen is on the forefront of revolutionizing antibiotic discovery to improve patient outcomes and public health.

Generated from the website